ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Orasis Initiates Clinical Studies of Novel Eye Drop Candidate for Presbyopia
November 06, 2020Orasis Pharmaceuticals announced the initiation of NEAR-1 and NEAR-2 Phase 3 clinical studies in the U.S., evaluating its novel eye drop candidate designed to improve near vision for people with presbyopia. -
Allergan Announces Positive Phase 3 Topline Results for Presbyopia Trial
November 05, 2020Allergan, an AbbVie company, announced the Phase 3 GEMINI 1 and 2 clinical trials evaluating the efficacy, safety and tolerability of investigational AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of symptoms associated with ...
Pharma Sources Insight January 2025
